1. Pharmacoeconomic Analysis and Clinical Outcomes of Staggered PK-Based Busulfan Dosing during Myeloablative Conditioning for Allogeneic Stem Cell Transplant Recipients 
Mohammed M. Elayan, Ted Y. Kim, Darby Siler, Carole Elledge, Paul J. Shaughnessy, Carlos Bachier 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S269-S270 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Example of staggered doing for target AUC 4823 µMol*minute. Recommended daily dose = 327 mg IV q24 hours X 4 days.
AWP 1 vial = $
Total savings = $
Biology of Blood and Marrow Transplantation  , S269-S270DOI: ( /j.bbmt )
Copyright © Terms and Conditions